Vascular endothelial growth factor and soft tissue sarcomas: Tumor expression correlates with grade

Annals of Surgical Oncology

Volumn 8, Issue 3, 2001, Pages 260-267

  Chao, C ^a   Al Saleem, T ^a   Brooks, J J ^a   Rogatko, A ^a   Kraybill, W G ^a   Eisenberg, B ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Immunohistochemistry; Soft tissue sarcoma; Tumor grade; Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; FEMALE; GENE OVEREXPRESSION; HIGH RISK PATIENT; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEW YORK; PHILADELPHIA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035074474     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.3.260     Document Type: Article

References (25)

1. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
2. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer
3. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma
4. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
5. Angiogenesis correlates with metastasis in melanoma
6. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma
7. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
8. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis
9. Vascular endothelial growth factor in squamous cell head and neck carcinoma: Expression and prognostic significance
10. Aortic smooth muscle cells express and secrete VEGF
11. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma
12. Cytokine regulation of angiogenesis in breast cancer: Role of tumor-associated macrophages
13. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells
14. The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis
15. Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas
16. Angiogenesis does not correlate with prognosis or expression of vascular endothelial growth factor in synovial sarcomas
17. Independent expression of serum VEGF and bFGF in patients with carcinoma and sarcoma
18. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
19. Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma
20. Neovascularity and clinical outcome in high grade extremity soft tissue sarcomas
21. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
22. Angiogenesis in carcinosarcomas of the uterus: Difference in the microvessel density and expression of vascular endothelial growth factor between the epithelial and mesenchymal elements
23. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
24. Paracrine expression of native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
25. Comparison of genetic changes in primary sarcomas and their pulmonary metastases